Table 3.
INT | CONTROL | 1P Value | |
---|---|---|---|
|
|||
Change | Change | ||
|
|||
Vo2peak | 2.36 ± 1.34 | 0.62 ± 2.16 | 0.313 |
TTE | 55.12 ± 16.35* | -15.42 ± 26.56 | 0.001 |
PPO | 18.86 ± 13.65* | -1.71 ± 12.84 | 0.004 |
FM | −1.96 ± 0.99* | −0.49 ± 1.62 | 0.011 |
%BF | −2.11 ± 0.88* | −0.49 ± 1.43 | 0.059 |
LM | 1.43 ± 1.80 | 1.17 ± 1.30 | 0.730 |
AFT | −11.29 ± 18.35 | −3.44 ± 9.21 | 0.321 |
| |||
Glucose | −0.13 ± 2.27 | −1.23 ± 3.75 | 0.600 |
Cholesterol | 0.91 ± 8.00 | 0.12 ± 13.27 | 0.921 |
Triglycerides | −9.00 ± 12.80 | −1.25 ± 20.60 | 0.528 |
HDL | 0.21 ± 2.44 | 1.70 ± 4.20 | 0.559 |
LDL | −2.18 ± 6.20 | −2.42 ± 10.20 | 0.968 |
Insulin | 0.26 ± 1.41 | 1.45 ± 2.25 | 0.384 |
Values are mean ± SD.
1P values are for the differences between the two groups, INT vs. CON
significant treatment effect p<0.05 via ANCOVA (post values are significantly different from each other, covarying for pre values).